3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
9
Motor Activity
7
Prostatic Neoplasms
3
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Insulin Resistance
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Diabetes Mellitus, Type 1
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Anxiety Disorders
1
Interventions
sotrovimab
1
ciclesonide
1
Niclosamide
1
High-Intensity Interval Training
1
Exercise
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lupus Erythematosus, Systemic
×
High-Intensity Interval Training
×
Clear all
NCT05478018
2025-09-09
LUPEX
Rigshospitalet, Denmark
Phase NA
Completed
55 enrolled